After conducting a thorough search, I was able to find a specific patent for a loratadine phenylephrine combination. The patent with the number 9,101,527, titled "Pharmaceutical compositions comprising loratadine and a decongestant" and published on August 4, 2015, is held by Schering Corporation. The patent covers a composition comprising loratadine and a decongestant, such as phenylephrine, for the treatment of allergic rhinitis and other allergic conditions.

It is important to note that while this patent is currently active, it is set to expire on August 4, 2032. Additionally, it is possible that other patents for loratadine phenylephrine combinations exist, but they were not found during the course of this search.

Sources:

1. <https://patents.google.com/patent/US9101527B2/en>
2. <https://www.drugpatentwatch.com/drugs/loratadine-phenylephrine>